Ophthalmology

The United States branded ophthalmic pharmaceuticals markets for age-related macular degeneration (AMD), chronic dry eye, ocular allergies, and ocular NSAIDs (for post-cataract and refractive surgery inflammation and pain) represent key markets with significant unmet medical needs, primarily among the growing aging population.